miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance / K. Pang ... [et al.]. -- ilustr., grafy, obr. -- Bibliogr. odkazy - Res. angl.

In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2020. -- s. 947-1191. -- ISSN 0028-2685. -- Vol. 67, no. 5 (2020), s. 1114-1121

1. nádory žalúdka 2. mikroRNA 3. biomarkery 4. rezistencia lieková nádorová 5. línia bunková nádorová

I. Pang, K.
II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 67, no. 5 (2020), s. 1114-1121

miRNA-15a-5p - oxaliplatina - rezistencia na cisplatinu - štúdia experimentálna